Trial · NCT01338415
Results by group60
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 60
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Treatment Emergent Adverse Events (AEs) up to 7 Days After Permanent Study Drug Discontinuation | Bosentan 2mg/kg b.i.d. | 29 | Participants | ||
| Treatment Emergent Adverse Events (AEs) up to 7 Days After Permanent Study Drug Discontinuation | Bosentan 2mg/kg t.i.d. | 26 | Participants | ||
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Stable WHO FC | 22 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Stable WHO FC | 25 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Improved WHO FC | 7 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Improved WHO FC | 3 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Worsened WHO FC | 4 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Worsened WHO FC | 3 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Stable WHO FC | 25 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Stable WHO FC | 25 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Improved WHO FC | 3 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Improved WHO FC | 3 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg b.i.d. | Worsened WHO FC | 5 | Participants | |
| Change From Baseline up to 18 Months of Study Treatment in the World Health Organization Functional Classification (WHO FC) | Bosentan 2mg/kg t.i.d. | Worsened WHO FC | 3 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg b.i.d. | Assessment by Physician / Stable | 16 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg t.i.d. | Assessment by Physician / Stable | 16 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg b.i.d. | Assessment by Physician / Improved | 10 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg t.i.d. | Assessment by Physician / Improved | 6 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg b.i.d. | Assessment by Physician / Worsened | 2 | Participants | |
| Change From Baseline up to 12 Months of Study Treatment in the Global Clinical Impression Scale (GCIS) | Bosentan 2mg/kg t.i.d. | Assessment by Physician / Worsened | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01338415/results